Evidence map›Paper›PMID 40620435›Full record

ReviewFrontiers in medicine2025

Risk stratification and scoring systems in upper and lower gastrointestinal bleeding: review of performance and limitations in the emergency department.

Fatemeh Mohammadyari, Amirreza Aflak, Mahta ZareDini, Reza Irandoost, Saeed Ghaffari, Arsham Gharib, Minaalsadat Roshanaei, Mazyar Tahavori, Sepehr Olangian-Tehrani

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fatemeh MohammadyariSchool of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Amirreza AflakSchool of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Mahta ZareDiniStudent Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Reza IrandoostStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Saeed GhaffariSchool of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Arsham GharibDepartment of Surgical Technology, Faculty of Medicine, Shiraz University of Medical Science, Shiraz, Iran.
Minaalsadat RoshanaeiIslamic Azad University Pharmaceutical Sciences, Tehran, Iran.
Mazyar TahavoriGastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Sepehr Olangian-TehraniSchool of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastrointestinal bleeding (GIB), which includes both upper GIB (variceal and non-variceal) and lower GIB, represents a significant cause of emergency department referrals. Main body: Given the potential risks of blood transfusion, re-bleeding, and mortality in these patients, it is essential to establish a system for prioritizing critical patients. Several risk stratification scoring systems have been developed based on patients' clinical characteristics and/or endoscopic findings. However, the optimal scoring system for each clinical scenario remains uncertain. Conclusion: In this study, we design the first comprehensive review and compare almost all of the upper gastrointestinal bleeding (UGIB), as well as lower gastrointestinal bleeding (LGIB) risk stratification scoring systems individually regarding their advantages, disadvantages, and limitations.

Indexed as

emergencygastrointestinal hemorrhageGIBprognosisscoring methodtriage

Identifiers

PMID40620435
PMCPMC12226541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.